Resistance Phenotype and Molecular Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Isolated from Nanjing Children’s Hospital in Jiangsu Province, China-Reference-Cited by-同舟云学术

Resistance Phenotype and Molecular Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Isolated from Nanjing Children’s Hospital in Jiangsu Province, China

Published:2022-09 Issue: Volume:Volume 15 Page:5435-5447
ISSN:1178-6973
Container-title:Infection and Drug Resistance
language:en
Short-container-title:IDR

Author:

Tao Guixiang^ORCID,Tan Hua,Ma Jingjing,Chen Qian

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases,Pharmacology

Reference53 articles.

1. Antibiotic Heteroresistance in Klebsiella pneumoniae

2. Colonization, Infection, and the Accessory Genome of Klebsiella pneumoniae

3. Dissemination of Carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) Among Carbapenem-Resistant Enterobacteriaceae Isolated From Adult and Children Patients in China

4. The Global Ascendency of OXA-48-Type Carbapenemases

5. Clonal Dissemination of OXA-232 Carbapenemase-Producing Klebsiella pneumoniae in Neonates

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emergence of ceftazidime-avibactam resistance in blaKPC-33-harbouring ST11 Klebsiella pneumoniae in a paediatric patient;International Journal of Antimicrobial Agents;2024-06

2. High prevalence of carbapenem resistance and clonal expansion of blaNDM gene in Klebsiella pneumoniae isolates in an Iranian referral pediatric hospital;Gut Pathogens;2024-03-28

3. Antimicrobial resistance of clinical bacterial isolates in China: current status and trends;JAC-Antimicrobial Resistance;2024-03-05

4. Clinical and molecular characteristics of Klebsiella pneumoniae infection in a tertiary general hospital of Wuhan, China;European Journal of Clinical Microbiology & Infectious Diseases;2023-12-01

5. Genomic Characteristics of Carbapenem-Resistant Klebsiella pneumoniae Isolated from Neonatal Patients in Southwest China During 2017–2021;Infection and Drug Resistance;2023-10